Skip to main
MASI

Masimo (MASI) Stock Forecast & Price Target

Masimo (MASI) Analyst Ratings

Based on 5 analyst ratings
Buy
Strong Buy 20%
Buy 40%
Hold 40%
Sell 0%
Strong Sell 0%

Bulls say

Masimo Corporation showcases a positive financial outlook supported by growth in its core SET pulse oximetry business and significant expansion in advanced monitoring parameters, including capnography and hemodynamics. The company is expected to achieve a notable EBIT margin increase, projected to reach 29.2% in FY26 and 29.8% in FY27, driven by both an expanding product portfolio and market share gains in key segments. Furthermore, the anticipated acceleration of total revenue growth, bolstered by new product launches and a strong international pulse oximetry market, reflects Masimo's strategic investment in innovation and market responsiveness.

Bears say

Masimo Corp faces significant financial headwinds, including an anticipated negative impact of $16M-$17M from tariffs in FY25, which is expected to adversely affect operating margins by approximately 110 basis points. Additional risks contributing to a negative outlook for the stock include heightened competition, potential delays in product regulatory approval, supply chain issues, and pricing pressures, all of which could hinder revenue growth and profitability metrics. Furthermore, reliance on hospital demand for capital equipment and fluctuating order timings has created uncertainty, resulting in a cautious revenue forecast that is likely to lead to unpredictable quarterly results.

Masimo (MASI) has been analyzed by 5 analysts, with a consensus rating of Buy. 20% of analysts recommend a Strong Buy, 40% recommend Buy, 40% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Masimo and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Masimo (MASI) Forecast

Analysts have given Masimo (MASI) a Buy based on their latest research and market trends.

According to 5 analysts, Masimo (MASI) has a Buy consensus rating as of Mar 21, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $187.40, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $187.40, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Masimo (MASI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.